This activity was provided by grants from Congressman Jamie Raskin and by the Substance Abuse and Mental Health Services Administration.

About the speaker

Holly A. Swartz is Professor of Psychiatry at the University of Pittsburgh School of Medicine. She received her undergraduate degree from Harvard College, medical degree from Albert Einstein College of Medicine, and completed her psychiatric residency training at New York Hospital / Cornell University School of Medicine. Dr. Swartz’s research focuses on understanding and optimizing psychosocial interventions for mood disorders. She is well known for her work evaluating Interpersonal Psychotherapy (IPT) and Interpersonal and Social Rhythm Therapy (IPSRT) as treatments for depression and bipolar disorder. Her research focuses on the role of IPSRT and pharmacotherapy in the management of bipolar II depression and IPT in the management of maternal depression. She is engaged in collaborative projects to develop computational frameworks to model dyadic interpersonal behaviors in relation to psychotherapy process and outcomes and to understand neural correlates of change in chronotherapeutic behavioral interventions. Her research has been funded by the National Institute of Health, National Science Foundation, and the Brain and Behavior Research Foundation.

Dr. Swartz is actively engaged in teaching, mentoring, and patient care.  A certified IPT and IPSRT trainer and supervisor, she has taught these therapies to thousands of clinicians across the globe. Dr. Swartz has held elected leadership positions for national and international professional organizations, including serving as President of the International Society for Interpersonal Psychotherapy (ISIPT ; 2015-17), Treasurer of the International Society of Bipolar Disorders (ISBD ; 2018-2023), and Board Member of the American Society of Clinical Psychopharmacology (ASCP ; 2021-2029).  She is the 2018 recipient of the Depression and Bipolar Association (DBSA) Gerald L. Klerman Senior Investigator Award in recognition of outstanding research contributing to the understanding, causes, diagnosis, and treatment of mood disorders. She is the author of over 100 publications, co-author of Bipolar II Disorder: Recognition, Understanding and Treatment (American Psychiatric Association Publishing, 2019), author of The Social Rhythm Therapy Workbook for Bipolar Disorder: Stabilize Your Circadian Rhythms to Reduce Stress, Manage Moods, and Prevent Future Episodes (New Harbinger Press, 2024), and Editor-in-Chief of the American Journal of Psychotherapy. She serves as a member of the Scientific Advisory Boards of DBSA and the International Bipolar Foundation.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

Holly A. Swartz, MD, reports royalties from Wolters Kluwer(UpToDate) and American Psychiatric Association Publications, Inc. She will discuss both FDA and non-FDA approved treatments for bipolar II disorder in this presentation. All relationships have been mitigated. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.